Analyst Price Target is $47.50
▲ +1,617.90% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Cocrystal Pharma in the last 3 months. The average price target is $47.50, with a high forecast of $60.00 and a low forecast of $35.00. The average price target represents a 1,617.90% upside from the last price of $2.77.
Current Consensus is
Buy
The current consensus among 2 investment analysts is to buy stock in Cocrystal Pharma. This Buy consensus rating has held steady for over two years.
Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded in 2008 and is headquartered in Bothell, WA.
Read More